《股市簡訊》中國翰森製藥一度漲2.1%，一款抗癌藥獲批第五項適應症

路透中文

01/09

《股市簡訊》中國<a href="https://laohu8.com/S/03692">翰森製藥</a>一度漲2.1%，一款抗癌藥獲批第五項適應症

* 由恒瑞醫藥600276.SS董事長孫飄揚之妻女控股的中國翰森製藥3692.HK周五早盤高開2.1%，目前漲幅收窄。

* 該公司此前公告稱，阿美樂（甲磺酸阿美替尼片）第五項適應症獲國家藥品監督管理局簽發藥品註冊證書，該適應症為阿美樂聯合培美曲塞和鉑類化療藥物適用於具有表皮生長因子受體外顯子19缺失或外顯子21(L858R)置換突變的局部晚期或轉移性非小細胞肺癌成人患者的一線治療。

* 恒⽣⽣物科技指數.HSBIO盤中一度跌1.4%。（完）

更多股市簡訊請點選CN-CMN-HOT

(發稿徐凱文；審校吳雲凌)

((kaiwen.xu@thomsonreuters.com))

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2602348144"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2602348144\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2602348144?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-01-09 10:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602348144","market":"hk","top_or_hot":-1,"title":"《股市簡訊》中國翰森製藥一度漲2.1%，一款抗癌藥獲批第五項適應症","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>《股市簡訊》中國<a href=\"https://laohu8.com/S/03692\">翰森製藥</a>一度漲2.1%，一款抗癌藥獲批第五項適應症</title></head><body><p>* 由<a href=\"https://laohu8.com/S/600276\">恒瑞醫藥</a><span>600276.SS</span>董事長孫飄揚之妻女控股的中國翰森製藥<span>3692.HK</span>周五早盤高開2.1%，目前漲幅收窄。</p><p>* 該公司此前<span>公告</span>稱，阿美樂（甲磺酸阿美替尼片）第五項適應症獲國家藥品監督管理局簽發藥品註冊證書，該適應症為阿美樂聯合培美曲塞和鉑類化療藥物適用於具有表皮生長因子受體外顯子19缺失或外顯子21(L858R)置換突變的局部晚期或轉移性非小細胞肺癌成人患者的一線治療。</p><p>* 恒⽣⽣物科技指數<span>.HSBIO</span>盤中一度跌1.4%。（完）</p><p>更多股市簡訊請點選<span>CN-CMN-HOT</span></p><p> (發稿 徐凱文；審校 吳雲凌)</p><p> ((kaiwen.xu@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《股市簡訊》中國翰森製藥一度漲2.1%，一款抗癌藥獲批第五項適應症</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《股市簡訊》中國翰森製藥一度漲2.1%，一款抗癌藥獲批第五項適應症\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time smaller\">2026-01-09 10:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>《股市簡訊》中國<a href=\"https://laohu8.com/S/03692\">翰森製藥</a>一度漲2.1%，一款抗癌藥獲批第五項適應症</title></head><body><p>* 由<a href=\"https://laohu8.com/S/600276\">恒瑞醫藥</a><span>600276.SS</span>董事長孫飄揚之妻女控股的中國翰森製藥<span>3692.HK</span>周五早盤高開2.1%，目前漲幅收窄。</p><p>* 該公司此前<span>公告</span>稱，阿美樂（甲磺酸阿美替尼片）第五項適應症獲國家藥品監督管理局簽發藥品註冊證書，該適應症為阿美樂聯合培美曲塞和鉑類化療藥物適用於具有表皮生長因子受體外顯子19缺失或外顯子21(L858R)置換突變的局部晚期或轉移性非小細胞肺癌成人患者的一線治療。</p><p>* 恒⽣⽣物科技指數<span>.HSBIO</span>盤中一度跌1.4%。（完）</p><p>更多股市簡訊請點選<span>CN-CMN-HOT</span></p><p> (發稿 徐凱文；審校 吳雲凌)</p><p> ((kaiwen.xu@thomsonreuters.com))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森製藥","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nL4T3YA07X:1","article_id":"2602348144","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602348144","pubTimestamp":1767926081,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"《股市簡訊》中國翰森製藥一度漲2.1%，一款抗癌藥獲批第五項適應症* 由恒瑞醫藥600276.SS董事長孫飄揚之妻女控股的中國翰森製藥3692.HK周五早盤高開2.1%，目前漲幅收窄。* 該公司此前公告稱，阿美樂第五項適應症獲國家藥品監督管理局簽發藥品註冊證書，該適應症為阿美樂聯合培美曲塞和鉑類化療藥物適用於具有表皮生長因子受體外顯子19缺失或外顯子21置換突變的局部晚期或轉移性非小細胞肺癌成人患者的一線治療。* 恒物科技指數.HSBIO盤中一度跌1.4%。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"03692":"翰森制药","BK1589":"北水核心资产","BK1583":"高瓴概念","BK1191":"制药"},"translate_title":"\"Stock Market Newsletter\" China Hansoh Pharmaceuticals once rose 2.1%, and an anticancer drug was approved for the fifth indication","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":0.9},"content_text":"《股市簡訊》中國翰森製藥一度漲2.1%，一款抗癌藥獲批第五項適應症* 由恒瑞醫藥600276.SS董事長孫飄揚之妻女控股的中國翰森製藥3692.HK周五早盤高開2.1%，目前漲幅收窄。* 該公司此前公告稱，阿美樂（甲磺酸阿美替尼片）第五項適應症獲國家藥品監督管理局簽發藥品註冊證書，該適應症為阿美樂聯合培美曲塞和鉑類化療藥物適用於具有表皮生長因子受體外顯子19缺失或外顯子21(L858R)置換突變的局部晚期或轉移性非小細胞肺癌成人患者的一線治療。* 恒⽣⽣物科技指數.HSBIO盤中一度跌1.4%。（完）更多股市簡訊請點選CN-CMN-HOT (發稿 徐凱文；審校 吳雲凌) ((kaiwen.xu@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}